Research programme: cancer vaccines - ImmunoFrontierAlternative Names: Cancer DNA vaccine research programme - ImmunoFrontier; CHP vaccine - ImmunoFrontier
Latest Information Update: 20 May 2010
At a glance
- Originator ImmunoFrontier
- Class Cancer vaccines; DNA vaccines; Protein-vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 20 May 2010 Preclinical development is ongoing in Japan
- 09 Nov 2004 Preclinical trials in Cancer in Japan (unspecified route)